CANNABIS POLAND AB ZY-10 Asset Resilience Ratio

Latest as of December 2025: 57.87%

CANNABIS POLAND AB ZY-10 asset resilience ratio. CANNABIS POLAND AB ZY-10 (8TE) has an Asset Resilience Ratio of 57.87% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CANNABIS POLAND AB ZY-10 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€1.74 Million
≈ $2.04 Million USD Cash + Short-term Investments

Total Assets

€3.01 Million
≈ $3.52 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of CANNABIS POLAND AB ZY-10 (2023–2025)

Asset resilience ratio of CANNABIS POLAND AB ZY-10 from 2023 to 2025. This chart shows how CANNABIS POLAND AB ZY-10's Asset Resilience Ratio has changed over time. Read CANNABIS POLAND AB ZY-10 debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down CANNABIS POLAND AB ZY-10's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CANNABIS POLAND AB ZY-10 balance sheet assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €1.74 Million 57.87%
Total Liquid Assets €1.74 Million 57.87%

Asset Resilience Insights

  • Very High Liquidity: CANNABIS POLAND AB ZY-10 maintains exceptional liquid asset reserves at 57.87% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

CANNABIS POLAND AB ZY-10 Industry Peers by Asset Resilience Ratio

Compare CANNABIS POLAND AB ZY-10's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Galderma Group N
SW:GALD
Drug Manufacturers - Specialty & Generic 3.56%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Drug Manufacturers - Specialty & Generic 1.38%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Cansino Biologics Inc
SHG:688185
Drug Manufacturers - Specialty & Generic 19.62%

CANNABIS POLAND AB ZY-10 Asset Resilience Ratio by Year (2023–2025)

CANNABIS POLAND AB ZY-10 asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for CANNABIS POLAND AB ZY-10.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 57.87% €1.74 Million
≈ $2.04 Million
€3.01 Million
≈ $3.52 Million
-16.04pp
2024-12-31 73.90% €3.09 Million
≈ $3.62 Million
€4.19 Million
≈ $4.90 Million
+10.44pp
2023-12-31 63.46% €1.16 Million
≈ $1.36 Million
€1.84 Million
≈ $2.15 Million
--
pp = percentage points

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.71 Million
€1.47 Million EUR
Market Cap Rank
#30341 Global
#2637 in Germany
Share Price
€0.02
Change (1 day)
-2.00%
52-Week Range
€0.02 - €0.05
All Time High
€0.69
About

Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more